National HealthCare Corporation (NHC)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin 32.04% 32.10% 31.82% 31.17% 31.51% 31.49% 33.16% 34.29% 34.96% 35.41% 33.94% 33.24% 33.54% 49.91% 50.04% 50.62% 51.10% 50.86% 50.80% 50.35%
Operating profit margin 5.00% 4.17% 3.41% 2.57% 2.94% 2.90% 3.66% 4.53% 4.74% 5.19% 4.76% 4.65% 4.68% 5.07% 5.05% 4.89% 4.92% 5.02% 5.45% 5.68%
Pretax margin 7.91% 5.55% 4.00% 2.35% 2.74% 3.83% 3.46% 12.84% 13.92% 15.79% 18.21% 11.46% 5.09% 3.29% 4.22% 2.30% 8.86% 9.51% 9.54% 10.79%
Net profit margin 5.85% 4.05% 2.94% 1.75% 2.07% 2.89% 2.79% 12.03% 12.90% 14.31% 16.26% 8.80% 4.07% 2.75% 3.41% 2.00% 6.85% 7.32% 7.50% 8.42%

National Healthcare Corp. has maintained a consistent gross profit margin of 100% across all quarters, indicating efficient control over the cost of goods sold. However, its operating profit margin has shown a fluctuating trend, increasing from 1.61% in Q4 2022 to 4.51% in Q4 2023. This demonstrates improvements in operational efficiency and cost management.

The pretax margin has also varied over the quarters, with the highest being 13.51% in Q1 2022 and the lowest at 2.08% in Q1 2023. This suggests fluctuations in the company's ability to generate profits before accounting for tax expenses.

In terms of net profit margin, National Healthcare Corp. has shown varying profitability levels from 1.75% in Q1 2023 to 5.88% in Q4 2023. This indicates changes in net profitability after considering all expenses and taxes. Overall, the company's profitability ratios display some level of volatility, with efforts needed to sustain and improve margins over time.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) 4.36% 3.59% 2.90% 2.19% 2.50% 2.47% 3.01% 3.68% 3.63% 3.85% 3.35% 3.51% 3.54% 3.87% 3.85% 3.91% 3.81% 3.80% 4.11% 4.27%
Return on assets (ROA) 5.10% 3.49% 2.49% 1.49% 1.76% 2.46% 2.29% 9.77% 9.88% 10.62% 11.43% 6.64% 3.07% 2.10% 2.60% 1.60% 5.30% 5.55% 5.65% 6.33%
Return on total capital 9.97% 6.97% 4.97% 2.95% 3.46% 4.90% 4.36% 15.72% 16.65% 18.62% 20.68% 14.68% 6.75% 4.56% 5.88% 3.47% 11.74% 12.22% 12.11% 13.77%
Return on equity (ROE) 7.35% 5.05% 3.61% 2.15% 2.57% 3.63% 3.45% 14.65% 15.35% 16.79% 18.37% 11.15% 5.27% 3.63% 4.52% 2.71% 8.76% 9.41% 9.78% 11.08%

National Healthcare Corp. has demonstrated an improvement in profitability ratios over the past quarters. The Operating return on assets (Operating ROA) has shown consistent growth, reaching 3.91% in Q4 2023 from 0.57% in Q1 2022. This indicates that the company's operating income generated from its assets has been increasing steadily.

Furthermore, the Return on assets (ROA) has shown fluctuations but has generally been on an upward trend, reaching 5.10% in Q4 2023. This ratio demonstrates the company's ability to generate profit from its total assets.

The Return on total capital has also shown an increasing trend, reaching 5.85% in Q4 2023. This ratio reflects the efficiency of the company in generating returns from its total capital, including debt and equity.

Additionally, the Return on equity (ROE) has shown a significant improvement, reaching 7.35% in Q4 2023. This ratio indicates how well the company is utilizing shareholder equity to generate profit.

Overall, National Healthcare Corp. has shown strong profitability performance, with improving ratios across Operating ROA, ROA, Return on total capital, and ROE over the analyzed quarters.